Gene:
ABCC2
ATP-binding cassette, sub-family C (CFTR/MRP), member 2

Overview

Alternate Names: ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 2; ABCC2; ATP-binding cassette sub-family C (CFTR\/MRP) member 2; Human canalicular multispecific organic anion transporter (cMOAT) mRNA, complete cds.; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; MRP2; MULTISPECIFIC ORGANIC ANION TRANSPORTER, CANALICULAR; CMOAT; OTTHUMP00000020267; canalicular multispecific organic anion transporter
Alternate Symbols: ABC30; CMOAT; DJS; KIAA1010; MRP2; U63970.1; cMRP
PharmGKB Accession Id: PA116

Details

Cytogenetic Location: chr10 : q24.2
GP mRNA Boundary: chr10 : 101532561 - 101601571
GP Gene Boundary: chr10 : 101522561 - 101604571
Strand: plus
Product Name: ATP-binding cassette, sub-family C (CFTR/MRP), member 2, canalicular multispecific organic anion transporter
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

Curated Annotations (Curated Annotation)

  1. rs717620 at chr10:101532568 in ABCC2, NANOGP6
    Shows decreased function in vitro, and is associated with several complications.
    Variant Name:
    ABCC2:(-)24C>T
    Evidence:
    PMID:17502832
  2. rs717620 at chr10:101532568 in ABCC2, NANOGP6
    Risk or phenotype-associated allele: 5'UTR (-)24C>T, mRNA 118C>T. Phenotype: In patients who received cyclosporine in addition to mycophenylate mofetil (MMF), there was a trend toward an association between the ABCC2 C-24T SNP and mycophenolic acid (MPA) AUC(0-12 h), but without any apparent additive effect: carriers of the CT genotype were associated with higher MPA AUC(0-12 h) compared with TT and CC homozygotes. Study size: 115. Study population/ethnicity: Caucasian cohort from the SOPHIE study cotreated with mycophenylate mofetil (MMF) and cyclosporine. Significance metric(s): p = 0.0087. Type of association: GN; PK
    Variant Name:
    ABCC2: 5'UTR (-)24C>T, mRNA 118C>T
    Related Drugs:
    cyclosporine, mycophenolate mofetil, mycophenolic acid
    Related Diseases:
    Organ Transplantation
    Evidence:
    PMID:19890249
  3. rs2273697 at chr10:101553805 in ABCC2
    Common variant, mostly found to have no association, but there was one exception.
    Variant Name:
    ABCC2:1249G>A
    Evidence:
    PMID:17083032
  4. rs2273697 at chr10:101553805 in ABCC2
    The A allele of this variant is associated in a gene dose dependent manner with the following phenotypes: 1) increased residual clearance of intravenous talinolol and 2) lower bioavailablilty of orally administered talinolol in healthy German subjects. However, this variant is not associated with alterations in intestinal ABCC2 mRNA or protein levels.
    Variant Name:
    ABCC2:c.1249G>A, ABCC2:V417I
    Related Drugs:
    talinolol
    Evidence:
    PMID:18334920
  5. rs3740066 at chr10:101594197 in ABCC2
    In strong LD with the causative (-)24C>T.
    Variant Name:
    ABCC2:3972C>T
    Evidence:
    PMID:17502832
  6. rs8187710 at chr10:101601284 in ABCC2
    Risk or phenotype-associated allele: A. Phenotype: This SNP in ABCC2 was associated with a higher accumulation of lopinavir in peripheral blood mononuclear cells of HIV-treated patients. Study size: 53. Type of association: GN.
    Related Drugs:
    lopinavir
    Related Diseases:
    HIV Infections
    Evidence:
    PMID:19842932

Non-Curated Annotations (Non-Curated Annotation)

  1. rs2804402 at chr10:101531573 in ABCC2, NANOGP6
    ABCC2*2 (−1019a>G) is associated with lower irinotecan clearance and with significant reduction in severe diarrhea in cancer patients.
    Variant Name:
    ABCC2: ¿1019a>G
    Related Drugs:
    irinotecan
    Related Diseases:
    Diarrhea, Neoplasms
    Evidence:
    PMID:19940846
  2. rs717620 at chr10:101532568 in ABCC2, NANOGP6
    The AUCs of irinotecan, SN-38, SN-38 glucuronide, and APC are influenced by rs3740066, rs2306283, rs35605, rs10276036, and rs717620 .
    Variant Name:
    ABCC2: ¿24C>T
    Related Drugs:
    irinotecan, SN-38
    Evidence:
    PMID:19940846
  3. rs3740066 at chr10:101594197 in ABCC2
    The AUCs of irinotecan, SN-38, SN-38 glucuronide, and APC are influenced by rs3740066, rs2306283, rs35605, rs10276036, and rs717620 .
    Variant Name:
    ABCC2: 3972C>T
    Related Drugs:
    irinotecan, SN-38
    Evidence:
    PMID:19940846
Variant names are different names that have been used in the literature and other resources to refer to the same variant. Non-curated variant information is accumulated solely by computational methods and has not been verified by the scientific staff at PharmGKB.

Non-Curated Information

A list of non-curated publications that mention this gene along with other genes is available.

Curated Information

The following drugs are in curated knowledge about this gene.

  Drug Class Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
antineoplastic agents
  •   
  • PD
  • PK
  •   
  • GN
Publications, Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
hmg coa reductase inhibitors
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
opioids
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
vinca alkaloids and analogues
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
xenobiotics
  •   
  •   
  •   
  • FA
  •   
Publications
  Drug Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
atorvastatin
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
carbamazepine
  •   
  • PD
  • PK
  • FA
  •   
Publications
Phenotype data available No genotype data Literature annotations available Not annotated
carboplatin
  • CO
  •   
  •   
  •   
  • GN
Publications
Phenotype data available No genotype data Literature annotations available Not annotated
cisplatin
  •   
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
codeine
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
cyanocobalamin
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
cyclosporine
  •   
  •   
  • PK
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
cytarabine
  • CO
  •   
  •   
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
daunorubicin
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
diclofenac
  •   
  •   
  • PK
  •   
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
digoxin
  •   
  •   
  •   
  • FA
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
docetaxel
  • CO
  •   
  • PK
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
etoposide
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
ezetimibe
  •   
  •   
  • PK
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
fluvastatin
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
folic acid
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
imatinib
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
indinavir
  •   
  •   
  • PK
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
irinotecan
  •   
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
Phenotype data available No genotype data Literature annotations available Not annotated
leucovorin
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
lopinavir
  •   
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
lovastatin
  •   
  •   
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
methotrexate
  • CO
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
mitoxantrone
  • CO
  •   
  •   
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
morphine
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
mycophenolate mofetil
  •   
  •   
  • PK
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
oxaliplatin
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
paclitaxel
  • CO
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
platinum
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
pravastatin
  •   
  •   
  • PK
  •   
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
pyridoxine
  •   
  • PD
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
rifampin
  •   
  •   
  • PK
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
rosuvastatin
  •   
  •   
  • PK
  •   
  •   
Pathways
Phenotype data available No genotype data Literature annotations available Not annotated
simvastatin
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
sirolimus
  •   
  •   
  • PK
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
tacrolimus
  • CO
  •   
  • PK
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
talinolol
  •   
  •   
  • PK
  •   
  • GN
Publications, Variants
Phenotype data available Genotype Data Available Literature annotations available Not annotated
tamoxifen
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
tenofovir
  •   
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
vinblastine
  •   
  •   
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
vincristine
  • CO
  •   
  • PK
  •   
  • GN
Publications, Pathways
No phenotype data No genotype data No literature annotations Not annotated
vindesine
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
vinorelbine
  •   
  •   
  • PK
  •   
  •   
Pathways

Non-Curated Information

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information

The following diseases are in curated knowledge about this gene.

  Disease Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
Adenocarcinoma
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Arthritis, Rheumatoid
  • CO
  • PD
  • PK
  •   
  • GN
Publications, Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Brain Neoplasms
  •   
  • PD
  •   
  • FA
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Breast Neoplasms
  • CO
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Carcinoma, Non-Small-Cell Lung
  •   
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Carcinoma, Renal Cell
  •   
  •   
  •   
  • FA
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Cardiovascular Diseases
  •   
  •   
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Colonic Neoplasms
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Colorectal Neoplasms
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Diarrhea
  •   
  • PD
  • PK
  •   
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Drug Toxicity
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
HIV
  •   
  •   
  • PK
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Hodgkin Disease
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Hypercholesterolemia
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Hyperlipidemias
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Hyperlipoproteinemia Type II
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Leukemia, Myeloid, Acute
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Leukopenia
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Liver Diseases
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Lung Neoplasms
  •   
  • PD
  • PK
  • FA
  •   
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Lymphoma
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Lymphoma, Non-Hodgkin
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Melanoma
  •   
  • PD
  • PK
  • FA
  •   
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Multiple Myeloma
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Muscular Diseases
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Myalgia unspecified
  •   
  •   
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Myocardial Infarction
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Myositis
  •   
  •   
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Neoplasms
  •   
  • PD
  • PK
  • FA
  •   
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Neutropenia
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Opioid-Related Disorders
  •   
  •   
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Organ Transplantation
  • CO
  •   
  • PK
  •   
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Ovarian Neoplasms
  •   
  • PD
  • PK
  • FA
  •   
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Pain
  •   
  •   
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Precursor Cell Lymphoblastic Leukemia-Lymphoma
  •   
  • PD
  • PK
  •   
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Prostatic Neoplasms
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Rhabdomyolysis
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Spina Bifida Cystica
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Transplantation
  • CO
  •   
  • PK
  •   
  •   
Publications

Non-Curated Information

A list of non-curated publications that mention this gene along with other diseases is available.

Curated Phenotype Datasets

These datasets are sorted alphabetically by title.

Additional Datasets

These datasets are minimally curated and are sorted alphabetically by title.

  1. Pharmacogenetic Pathway Analysis of Irinotecan

Downloads

You must sign in before you can download data.

LinkOuts

Ref Seq NT Accession:
AC_000053
AC_000142
NC_000010
NG_011798
NT_030059
NW_001838006
NW_924884
UniProtKB Accesssion:
MRP2_HUMAN (Q92887)
Ensembl ID:
ENSG00000023839
GenAtlas ID:
ABCC2
GeneCard ID:
ABCC2
SOURCE ID:
ABCC2
MutDB ID:
ABCC2
PromoLign ID:
ortho_4177
HuGE ID:
ABCC2
Comparative Toxicogenomics Acc ID:
1244
ModBase:
Q92887

Common Searches

Non-Curated Publications

A list of non-curated publications that mention this gene is available.

The PharmGKB is financially supported by the NIH/ NIGMS and is managed at Stanford University (U01GM61374).
©2001-2010 PharmGKB.